Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Rossi

Showing results (131-140 of 186) with videos related to

Pageof 19
Sort By:
Frontiers in Oncology|October 20, 2023
Unraveling the impact of upfront chemotherapy and proton beam therapy on treatment outcome and follow-up in central nervous system germ cell tumors: a single center experienceGiada Del Baldo, Sabina Vennarini, Maristella Toniutti, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Molecular Characterization of Medulloblastoma in a Patient with Neurofibromatosis Type 1: Case Report and Literature ReviewMarco Ranalli, Alessandra Boni, Anna Maria Caroleo, et al.
Brain Pathology (Zurich, Switzerland)|September 30, 2020
The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literatureOscar Lopez-Nunez, Barbara Cafferata, Mariarita Santi, et al.
Nucleic Acids Research|June 24, 2026
Ubiquitin-dependent degradation of p27Kip1 and p21Waf1/Cip1 by AMBRA1 ensures G1 and S phase progression and limits replication stressGiacomo Milletti, Giulia Cadeddu, Alba Adelantado-Rubio, et al.
Clinical Genetics|March 18, 2021
Expansion of the clinical and molecular spectrum of an XPD-related disorder linked to biallelic mutations in ERCC2 geneEmanuele Agolini, Elena Botta, Mariachiara Lodi, et al.
Oncotarget|April 21, 2016
Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumorsSabrina Rossi, Marta Sbaraglia, Marta Campo Dell'Orto, et al.
Pathologica|December 19, 2022
Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO ClassificationFrancesca Gianno, Isabella Giovannoni, Barbara Cafferata, et al.
NPJ Precision Oncology|April 18, 2024
Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profilingLucia Pedace, Simone Pizzi, Luana Abballe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2016
Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 SyndromeDaniela Gasparotto, Sabrina Rossi, Maurizio Polano, et al.
Acta Neuropathologica Communications|May 12, 2025
Expanding clinicopathologic knowledge in high-grade glioma with pleomorphic and pseudopapillary features (HPAP): a report of two casesSabrina Rossi, Isabella Giovannoni, Sara Patrizi, et al.
Pageof 19

Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
Frontiers in Oncology|October 20, 2023
Unraveling the impact of upfront chemotherapy and proton beam therapy on treatment outcome and follow-up in central nervous system germ cell tumors: a single center experienceGiada Del Baldo, Sabina Vennarini, Maristella Toniutti, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Molecular Characterization of Medulloblastoma in a Patient with Neurofibromatosis Type 1: Case Report and Literature ReviewMarco Ranalli, Alessandra Boni, Anna Maria Caroleo, et al.
Brain Pathology (Zurich, Switzerland)|September 30, 2020
The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literatureOscar Lopez-Nunez, Barbara Cafferata, Mariarita Santi, et al.
Nucleic Acids Research|June 24, 2026
Ubiquitin-dependent degradation of p27Kip1 and p21Waf1/Cip1 by AMBRA1 ensures G1 and S phase progression and limits replication stressGiacomo Milletti, Giulia Cadeddu, Alba Adelantado-Rubio, et al.
Clinical Genetics|March 18, 2021
Expansion of the clinical and molecular spectrum of an XPD-related disorder linked to biallelic mutations in ERCC2 geneEmanuele Agolini, Elena Botta, Mariachiara Lodi, et al.
Oncotarget|April 21, 2016
Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumorsSabrina Rossi, Marta Sbaraglia, Marta Campo Dell'Orto, et al.
Pathologica|December 19, 2022
Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO ClassificationFrancesca Gianno, Isabella Giovannoni, Barbara Cafferata, et al.
NPJ Precision Oncology|April 18, 2024
Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profilingLucia Pedace, Simone Pizzi, Luana Abballe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2016
Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 SyndromeDaniela Gasparotto, Sabrina Rossi, Maurizio Polano, et al.
Acta Neuropathologica Communications|May 12, 2025
Expanding clinicopathologic knowledge in high-grade glioma with pleomorphic and pseudopapillary features (HPAP): a report of two casesSabrina Rossi, Isabella Giovannoni, Sara Patrizi, et al.
Pageof 19